Br J Cancer 118(9):12481254 Fall K, Garmo H, Gudbjrnsdottir S, Stattin P, Zethelius B (2013) Diabetes mellitus and prostate cancer risk
71% stop taking GLP-1s by 12 months 6 74% report gastrointestinal symptoms 7 65% report NO increased exercise after starting medication 8 This is why the Noom GLP-1 Rx Program with Noom GLP-1 Companion exists
doi: 10.1210/clinem/dgab927 24 ZuckerIZloofYBardugoATsurAMLutskiMCohenYet al
In diabetic models, microencapsulated Pleurotus cystidiosus improved glucose metabolism and reduced inflammation by lowering TNF- and IL-1, increasing insulin and GLP-1 secretion, and inhibiting DPP-4 activity, demonstrating combined antidiabetic and anti-inflammatory benefits (Ratnaningtyas et al., 2025)
Legitimate research chemical suppliers maintain identifiable business addresses, customer service contacts, and often business registration records
This approach maintains physiologic regulation and reduces the risks associated with direct HGH replacement therapy